China Shineway Pharmaceutical Group Limited Return on Equity

The latest ROE for CSWYY is 19.7%. That is above the sector sector average of 11.85%. Investors often review this figure alongside China Shineway Pharmaceutical Group Limited's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, CSWYY currently prints 19.7% for ROE, while the sector average sits near 11.85%. That is roughly 66.2% above the sector mean. Large gaps often invite a closer look at China Shineway Pharmaceutical Group Limited's growth, margins, and balance sheet.

Return on Equity shows how effectively China Shineway Pharmaceutical Group Limited converts resources into returns. At 19.7%, CSWYY may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CSWYY's ROE (19.7%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.